Logo image
Back
Endovascular Versus Medical Management in Distal Medium Vessel Occlusion Stroke: The DUSK Study
Journal article   Peer reviewed

Endovascular Versus Medical Management in Distal Medium Vessel Occlusion Stroke: The DUSK Study

Mahmoud H Mohammaden, Lorena Souza Viana, Hend Abdelhamid, Marta Olive-Gadea, Marc Rodrigo-Gisbert, Manuel Requena, Pedro N Martins, Stavros Matsoukas, Braxton R Schuldt, Johanna T Fifi, …
Stroke (1970), Vol.55(6), pp.1489-1497
06/2024
DOI: 10.1161/STROKEAHA.123.045228
PMID: 38787927

View Online

Abstract

Endovascular treatment (EVT) is part of the usual care for proximal vessel occlusion strokes. However, the safety and effectiveness of EVT for distal medium vessel occlusions remain unclear. We sought to compare the clinical outcomes of EVT to medical management (MM) for isolated distal medium vessel occlusions. This is a retrospective analysis of prospectively collected data from seven comprehensive stroke centers. Patients were included if they had isolated distal medium vessel occlusion strokes due to middle cerebral artery M3/M4, anterior cerebral artery A2/A3, or posterior cerebral artery P1/P2 segments. Patients treated with EVT or MM were compared with multivariable logistic regression and inverse probability of treatment weighting. The primary outcome was the shift in the degree of disability as measured by the modified Rankin Scale (mRS) at 90 days. Secondary outcomes included 90-day good (mRS score, 0-2) and excellent (mRS score, 0-1) outcomes. Safety measures included symptomatic intracranial hemorrhage and 90-day mortality. A total of 321 patients were included in the analysis (EVT, 179; MM, 142; 40.8% treated with intravenous thrombolysis). In the inverse probability of treatment weighting model, there were no significant differences between EVT and MM in terms of the overall degree of disability (mRS ordinal shift; adjusted odds ratio [aOR], 1.25 [95% CI, 0.95-1.64]; =0.110), rates of good (mRS score, 0-2; aOR, 1.32 [95% CI, 0.97-1.80]; =0.075) and excellent (aOR, 1.32 [95% CI, 0.94-1.85]; =0.098) outcomes, or mortality (aOR, 1.20 [95% CI, 0.78-1.85]; =0.395) at 90 days. The multivariable regression model showed similar findings. Moreover, there was no difference between EVT and MM in rates of symptomatic intracranial hemorrhage in the multivariable regression model (aOR, 0.57 [95% CI, 0.21-1.58]; =0.277), but the inverse probability of treatment weighting model showed a lower likelihood of symptomatic intracranial hemorrhage (aOR, 0.46 [95% CI, 0.24-0.85]; =0.013) in the EVT group. This multicenter study failed to demonstrate any significant outcome differences among patients with isolated distal medium vessel occlusions treated with EVT versus MM. These findings reinforce clinical equipoise. Randomized clinical trials are ongoing and will provide more definite evidence.
 Aged Aged, 80 and over Endovascular Procedures - methods Female Humans Infarction, Middle Cerebral Artery - surgery Ischemic Stroke - surgery Ischemic Stroke - therapy Male Middle Aged Retrospective Studies Stroke - surgery Stroke - therapy Thrombolytic Therapy - methods Treatment Outcome

Details

Metrics

9 Record Views
30 Times Cited - Web of Science
Logo image